GlaxoSmithKline to look for early-stage assets - (NASDAQ via NewsPoints Desk)

  • GlaxoSmithKline CEO Emma Walmsley indicated Tuesday that the drugmaker will actively seek to acquire early-stage assets and partner with companies, as reported in NASDAQ.

  • She added GlaxoSmithKline is also likely to evaluate licensing deals and it will continue to invest in early-stage HIV treatments.

To read more NewsPoints articles, click here.